The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of irinotecan and bevacizumab plus alternate day S-1 as second-line treatment in patients with metastatic colorectal cancer.
 
Chihiro Tanaka
No Relationships to Disclose
 
Chu Matsuda
No Relationships to Disclose
 
Ken Kondo
No Relationships to Disclose
 
Yukihiko Tokunaga
No Relationships to Disclose
 
Takao Takahashi
No Relationships to Disclose
 
Chihiro Kosugi
No Relationships to Disclose
 
Hiroyoshi Takemoto
No Relationships to Disclose
 
Shigeyoshi Iwamoto
No Relationships to Disclose
 
Koji Oba
No Relationships to Disclose
 
Junichi Sakamoto
No Relationships to Disclose
 
Hideyuki Mishima
Honoraria - Chugai Pharma; Takeda
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)